Amgen Will Buy Celgene Drug in $13.4 Billion Antitrust Sale

(Bloomberg) -- Amgen Inc. will pay $13.4 billion for a blockbuster psoriasis drug from Celgene Corp., which is shedding the asset in order to win antitrust regulators’ sign-off for its $74 billion ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.